Psikiyatri Tedavisi Alan Hastaların Tedaviye Uyumları ile Algıladıkları Sosyal Destek ve İyileşme Durumları Arasındaki İlişki

Öz

Amaç: Bu araştırma, ayaktan tedavi gören psikiyatri hastalarının iyileşme durumlarının algıladıkları sosyal destek ve tedaviye uyumları ile ilişkisini ve etkileyen faktörleri belirlemek amacıyla yapılmıştır. Materyal ve Metot: Bu çalışma, tanımlayıcı, kesitsel ve ilişkisel tipte bir araştırmadır. Veri toplamak için 'Hasta Bilgi Formu', 'Morisky İlaç Uyumu Ölçeği (MMAS-4)', 'İyileşme Değerlendirme Ölçeği (RAS)' ve 'Çok Boyutlu Algılanan Sosyal Destek Ölçeği (MSPSS) kullanıldı. Bulgular: Katılımcıların %22,3'ünün tedavi uyumu düşüktü. Tedaviye uyum ölçeği ile RAS kişisel güven ve umut, RAS yardım isteme istekliliği ve RAS toplam puanları arasında; çok boyutlu algılanan sosyal destek ölçeğinin tüm boyutları ile RAS'ın tüm alt boyutları arasında istatistiksel olarak anlamlı ilişkiler bulundu (p<0,05) ve tanının tedaviye uyum puanlarını etkilediği belirlendi (F=5,041, p<0,05). RAS toplam puanlarının tedaviye uyum üzerinde olumsuz bir etkisi vardı (β= -0,011; p<0,050). RAS toplam puanları MSPSS puanları üzerinde olumlu bir etkiye sahipti (β= 0,447; p<0,001). Sonuç: Çalışmada, iyileşme durumu arttıkça hastaların tedaviye uyumunun azaldığı ve algılanan sosyal destek arttıkça iyileşme düzeyinin arttığı bulunmuştur.

Anahtar Kelimeler

• Algılanan sosyal destek
• iyileşme
• ruhsal hastalık
• tedaviye uyum

The Relationship between Treatment Adherence, Social Support and Recovery Status of Patients Receiving Psychiatric Treatment

Abstract

Objective: This research was performed to determine the correlations and effective factors for treatment adherence with perceived social support and the recovery status of psychiatric patients receiving outpatient treatment. Materials and Methods: This study was descriptive, cross-sectional, and relational. Data collection tools used were the ‘Patient Information Form’, ‘Morisky Medication-taking Adherence Scale (MMAS-4)’, ‘Recovery Assessment Scale (RAS)’, and the ‘Multidimensional Scale of Perceived Social Support (MSPSS)’. Results: Of the participants, 22.3% had low treatment adherence. There were statistically significant correlations between the treatment adherence scale with the RAS personal confidence and hope, RAS willingness to ask for help subscales, and RAS total points between all dimensions of the multidimensional perceived social support scale and all dimensions of the RAS (p<0.05). The diagnosis was determined to affect treatment adherence points (F=5.041, p<0.05). RAS total points had a negative effect on treatment adherence (β= -0.011; p<0.050) but a positive effect on MSPSS points (β= 0.447; p<0.001). Conclusion: In the study, it was found that as recovery status increased, the patient’s adherence to treatment decreased, and as the perceived social support increased, the level of recovery (RAS) increased.

Keywords

• Mental disease
• perceived social support
• recovery
• treatment adherence

Kaynakça

1. El-Missiry A, Elbatrawy A, El Missiry M, Moneim DA, Ali R, Essawy H. Comparing cognitive functions in medication adherent and non-adherent patients with schizophrenia. J. Psychiatr. Res. 2015;70:106–112. doi:10.1016/j.jpsychires.2015.09.006
2. MacKenzie NE, Kowalchuk C, Agarwal SM, et al. Antipsychotics, metabolic adverse effects, and cognitive function in schizophrenia. Front. Psychiatr. 2018; 9:622. doi:10.3389/fpsyt.2018.00622
3. Haddad PM, Brain C, Scott J. Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies. Patient Relat. Outcome Meas. 2014;5:43–62. doi:10.2147/PROM.S42735
4. McCutcheon R, Beck K, Bloomfield MA, Marques TR, Rogdaki M, Howes OD. Treatment resistant or resistant to treatment? Antipsychotic plasma levels in patients with poorly controlled psychotic symptoms. J. Psychopharmacol. 2015;29:892–897. doi:10.1177/0269881115576688
5. McCutcheon R, Beck K, D’Ambrosio E, et al. Antipsychotic plasma levels in the assessment of poor treatment response in schizophrenia. Acta Psychiatr. Scand. 2018;137:39–46. doi:10.1111/acps.12825
6. El-Menem SA, Harfush AE-G, Gemeay EM. Perceived social support and medication adherence in patients with psychiatric disorders. Int J Novel Res Healthcare Nurs. 2017;4 (3):157-169.
7. Levin JB, Krivenko A, Howland M, Sclachet R, Sajatovic M. Medication adherence in patients with bipolar disorder: a comprehensive review. CNS drugs. 2016;819-835. doi:10.1007/s40263-016-0368-x
8. Barros, REM., de Azevedo Marques JM, Santos JLF, Zuardi AW, Del-Ben CM. Impact of length of stay for first psychiatric admissions on the ratio of readmissions in subsequent years in a large Brazilian catchment area. Soc Psychiatry Psychiatr Epidemiol. 2016;51:575-587. doi:10.1007/s00127-016-1175-x

9. Ose SO, Kalseth J, Ådnanes M, Tveit T, Lilleeng SE. Unplanned admissions to inpatient psychiatric treatment and services received prior to admission. Health policy. 2017;122(4):359-366. doi:10.1016/j.healthpol.2017.12.006
10. Jacob KS. Perspectives about mental health, illness, and recovery. Curr Opin Psychiatry. 2017;30:334–338. doi:10.1097/YCO.0000000000000346
11. Petros R, Solomon P, Linz SJ, DeCesaris M, Hanrahan NP. Capabilities Approach: Contextualizing Participants’ Perspectives on Systems Barriers to Recovery. Int J Ment Health. 2016;45(4):262–278. doi:10.1080/00207411.2016.1238742
12. Konkoly Thege B, Ham E, Ball LC. A Factor analytic investigation of the Person-in-Recovery and Provider Versions of the Revised Recovery Self-Assessment (RSA-R). Eval Health Prof. 2017;40(4):505-516. doi:10.1177/0163278716674247
13. Martín-Subero M, Berk L, Dodd S, et al. Quality of life in bipolar and schizoaffective disorder — A naturalistic approach. Compr Psychiatry. 2014;55(7):1540–1545. doi:10.1016/j.comppsych.2014.05.009
14. Leese D, Smithies L, Green J. Recovery-focused practice in mental health. Nurs Times. 2014;110(12):20-22.
15. El Abdellati K, De Picker L, Morrens M. Antipsychotic treatment failure: a systematic review on risk factors and interventions for treatment adherence in psychosis. Front Neurosci. 2020;14:531763. doi:10.3389/fnins.2020.531763
16. Yılmaz S. Psikiyatri hastalarında ilaç yan etkileri ve ilaç uyumu İstanbul Üniversitesi Sağlık Bilimleri Enstitüsü Yüksek Lisans Tezi. İstanbul, Türkiye, 2004
17. Corrigan PW, Salzer M, Ralph RO, Sangster Y, Keck L. Examining the factor structure of the recovery assessment scale. Schizophr Bull. 2004;30(4):1035–1041. doi:10.1093/oxfordjournals.schbul.a007118
18. Güler C. Türkçe iyileşmeyi değerlendirme ölçeği. geçerlilik ve güvenilirlik. Ege Üniv Sağlık Bilimleri Enstitüsü, Yüksek Lisans Tezi. İzmir, Türkiye, 2017.
19. Eker D, Arkar H. Factorial validity and reliability of the multidimensional perceived social support scale. Turk J Psychiatry. 1995;10(34):17-25.
20. Lien YJ, Chang HA, Kao YC, Tzeng NS, Lu CW, Loh CH. The impact of cognitive insight, self-stigma, and medication adherence on the quality of life in patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2018;268(1):27-38. doi:10.1007/s00406-017-0829-3
21. Kamaradova D, Latalova K, Prasko J, et al. Connection between self-stigma, adherence to treatment, and discontinuation of medication. Patient Prefer Adher. 2016;10:1289-1298. doi:10.2147/PPA.S99136
22. Polat H, Uğur K. Investigation of the relationship between forensic psychiatry patients' violent behaviors, adherence to treatment and hope levels. J Clin Psychiatry. 2021;24(4):491-498. doi:10.5505/kpd.2021.84704
23. Mendelsohn, Bachar R. Approach to the Non‐Adherent Patient. Mount Sinai Expert Guides: Psychiatry. 2016;343-345.
24. Velligan, DI, Riolo SA, Weston CG. Adherence to medication in psychiatric disorders. Psychiatry. 2015:2382-2397. doi:10.1002/9781118753378.ch115
25. Berghöfer A, Martin L, Hense S, Weinmann S, Roll S. Quality of life in patients with severe mental illness: a cross‑sectional survey in an integrated outpatient health care model. Qual Life Res. 2020;29(8):2073–2087. doi:10.1007/s11136-020-02470-0
26. Aylaz R, Kılınç G. The relationship between treatment adherence and social support in psychiatric patients in the east of Turkey. Arch Psychiatr Nurs. 2017;31(2):157-163. doi:10.1016/j.apnu.2016.09.008
27. Hengartner MP, Passalacqua S, Andreae A, Rössler W, von Wyl A. The role of perceived social support after psychiatric hospitalization: Post hoc analysis of a randomized controlled trial testing the effectiveness of a transitional intervention. Int J Soc Psychiatry. 2017;63(4):297–306. doi:10.1177/0020764017700664
28. Kelleci M, Ata EE. Psikiyatri kliniğinde yatan hastaların ilaç uyumları ve sosyal destekle ilişkisi. Psikiyatri Hemşireliği Dergisi. 2011;2(3):105-110.
29. El-Monshed A, Amr M. Association between perceived social support and recovery among patients with schizophrenia. Int J Africa Nurs Sci. 2020;13:100236. doi:10.1016/j.ijans.2020.100236